Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
16 weeks 11 vials Covers a 4-week 300 mcg phase plus 12 weeks at 500 mcg
The Sikiric group has consistently characterized BPC-157 as resistant to degradation in human gastric juice, a property attributed to its compact 15-residue length, its five proline residues (which disrupt protease recognition motifs), and the absence of cysteine-bridgedependent tertiary structure (Sikiric et al., 2018)
Della Torre S et al
Known for its healing properties, BPC 157 injections are gaining attention as an innovative therapy for people suffering from various injuries and chronic conditions
We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to confirm an absolute chemical purity profile of 99% or greater for the active small molecule matrix before encapsulation
